Carl Desantis - Nov 3, 2021 Form 4 Insider Report for INTEGRATED BIOPHARMA INC (INBP)

Role: Director, 10%+ Owner
Signature: /s/ Carl DeSantis
Stock symbol: INBP
Transactions as of: Nov 3, 2021
Transactions value $: $0
Form type: 4
Date filed: 11/4/2021, 12:16 PM
Previous filing: Jun 15, 2021
Next filing: Dec 2, 2021
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INBP	Stock Option (right to buy)	Award	$0	+50K		$0.00	50K	Nov 3, 2021	Common Stock	50K		Direct	F1, F2

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Exercise Price of the Stock Option will be 110% of the closing price of the Issuer's Common Stock five trading days after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2021, with the Securities and Exchange Commission(the "Issue Date").
F2	The option vests and becomes exercisable as follows: 25% (12,500 shares) on the Issue Date, 25% (12,500 shares) on December 31, 2021, 25% (12,500 shares) on March 31, 2022 and 25% (12,500 shares) on June 30, 2022.